56
Participants
Start Date
May 14, 2014
Primary Completion Date
October 17, 2018
Study Completion Date
October 17, 2018
[18F]-FET-βAG-TOCA
Single I.V. administration of a \[18F\]fluoroethyl triazole \[Tyr3\]Octreotate (\[18F\]-FET-βAG-TOCA). Patients will receive a maximum injected dose of 370MBq and will subsequently undergo PET/CT imaging.
Collaborators (1)
Imperial College Healthcare NHS Trust
OTHER
Royal Marsden NHS Foundation Trust
OTHER
University of Manchester
OTHER
The Christie NHS Foundation Trust
OTHER
Invicro
OTHER
Newcastle University
OTHER
Imperial College London
OTHER